However, some studies have reported lower Pin1 expression and activity, along with oxidative modifications, is associated with mild cognitive impairment, the hippocampus in AD, and adriamycin-induced cognitive dysfunction (Butterfield et al., 2006; Sultana et al., 2006; Joshi et al., 2010). The gene discussed is PIN1; the disease is Alzheimer disease.